Literature DB >> 6705332

Changes in erythrocyte sedimentation rate and C-reactive protein after total hip arthroplasty.

K Aalto, K Osterman, H Peltola, J Räsänen.   

Abstract

Uncomplicated total hip arthroplasty (THA) was performed in 40 osteoarthritic patients, and changes in erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels were registered. The follow-up period was one year. Preoperative ESR appeared to be slightly elevated, and CRP levels were normal, with no exceptions. A postoperative maximum ESR of 64 mm/hour was reached six days after surgery. A slow decrease followed, but ESR remained slightly elevated one year later. The changes in CRP were more rapid; a maximum of 134 mg/l was registered on the second day after surgery, and the values were consistently normalized three weeks after surgery. Thus, uneventful recovery after THA seems to be indicated by a normalizing CRP, regardless of ESR values.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6705332

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  26 in total

1.  Diagnosis of infection in hip and knee revision surgery: intraoperative frozen section analysis.

Authors:  Alberto Francés Borrego; Fernando Marco Martínez; Juan Luis Cebrian Parra; David Serfaty Grañeda; Rodrigo García Crespo; Luis López-Durán Stern
Journal:  Int Orthop       Date:  2006-03-18       Impact factor: 3.075

2.  The utility of erythrocyte sedimentation rate values and white blood cell counts after spinal deformity surgery in the early (≤3 months) post-operative period.

Authors:  Margaret G Kuhn; Lawrence G Lenke; Keith H Bridwell; June C O'Donnell; Scott J Luhmann
Journal:  J Child Orthop       Date:  2012-03-09       Impact factor: 1.548

3.  Effects of periarticular steroid injection on knee function and the inflammatory response following Unicondylar Knee Arthroplasty.

Authors:  Yung Chuan Sean Ng; Ngai Nung Lo; Kuang Ying Yang; Shi Lu Chia; Hwei Chi Chong; Seng Jin Yeo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-01       Impact factor: 4.342

4.  Characterizing the Acute Phase Response in Healthy Patients Following Total Joint Arthroplasty: Predictable and Consistent.

Authors:  William K Oelsner; Stephen M Engstrom; Michael A Benvenuti; Thomas J An; Richard A Jacobson; Gregory G Polkowski; Jonathan G Schoenecker
Journal:  J Arthroplasty       Date:  2016-07-15       Impact factor: 4.757

5.  C-reactive protein levels after 4 types of arthroplasty.

Authors:  Hao Shen; Nanxin Zhang; Xianlong Zhang; Weiping Ji
Journal:  Acta Orthop       Date:  2009-06       Impact factor: 3.717

6.  C-reactive protein, erythrocyte sedimentation rate and orthopedic implant infection.

Authors:  Kerryl E Piper; Marta Fernandez-Sampedro; Kathryn E Steckelberg; Jayawant N Mandrekar; Melissa J Karau; James M Steckelberg; Elie F Berbari; Douglas R Osmon; Arlen D Hanssen; David G Lewallen; Robert H Cofield; John W Sperling; Joaquin Sanchez-Sotelo; Paul M Huddleston; Mark B Dekutoski; Michael Yaszemski; Bradford Currier; Robin Patel
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

7.  Changes in C-reactive protein and erythrocyte sedimentation rate after hip fractures.

Authors:  N Ellitsgaard; A P Andersson; K V Jensen; M Jorgensen
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

8.  The C-reactive protein (CRP) in patients with long bone fractures and after arthroplasty.

Authors:  S I Yoon; S S Lim; J D Rha; Y H Kim; J S Kang; G H Baek; K H Yang
Journal:  Int Orthop       Date:  1993       Impact factor: 3.075

9.  Diagnosis of periprosthetic joint infection: the threshold for serological markers.

Authors:  Pouya Alijanipour; Hooman Bakhshi; Javad Parvizi
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

10.  Normative Temporal Values of CRP and ESR in Unilateral and Staged Bilateral TKA.

Authors:  Kwan Kyu Park; Tae Kyun Kim; Chong Bum Chang; Su Won Yoon; Kyoung Un Park
Journal:  Clin Orthop Relat Res       Date:  2008-01-03       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.